PURPOSE: General population reference data are useful in the interpretation of health-related quality of life (HRQoL) results, but for the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30), such data have been published for only seven countries. In 1992, Danish general population data were collected from women only for EORTC QLQ-C30 version 1. Since no Danish reference data exists for men and women for the QLQ-C30 version 3.0, the aims of this study were to generate such data and to investigate the associations between EORTC QLQ-C30 outcomes and age, gender and morbidity, as well as trends over time. METHODS: An age- and gender-stratified random sample of 3,080 Danes was drawn from the Danish Civil Registration System. The EORTC QLQ-C30 was administered electronically and by mail along with a short questionnaire concerning socio-demographics/morbidity. RESULTS: Responses were obtained from 1,832 individuals (60.1% of 3,009 eligible individuals). Response rates varied across age groups, ranging from 41.9% (20-29 years) to 76.1% (70-79 years). The majority of subscales were strongly associated with age and morbidity. Between genders only small, but clinically meaningful and statistically significant differences were found in five out of fifteen scales. When comparing Danish women 20 years ago and today, a tendency toward slightly improved function/reduced symptoms was observed, but the differences were small and statistically significant in only three subscales. CONCLUSION: This study is the first to present Danish general population reference values for the EORTC QLQ-C30 version 3.0. Age and morbidity are important potential confounders that must be taken into account in HRQoL studies.
PURPOSE: General population reference data are useful in the interpretation of health-related quality of life (HRQoL) results, but for the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30), such data have been published for only seven countries. In 1992, Danish general population data were collected from women only for EORTC QLQ-C30 version 1. Since no Danish reference data exists for men and women for the QLQ-C30 version 3.0, the aims of this study were to generate such data and to investigate the associations between EORTC QLQ-C30 outcomes and age, gender and morbidity, as well as trends over time. METHODS: An age- and gender-stratified random sample of 3,080 Danes was drawn from the Danish Civil Registration System. The EORTC QLQ-C30 was administered electronically and by mail along with a short questionnaire concerning socio-demographics/morbidity. RESULTS: Responses were obtained from 1,832 individuals (60.1% of 3,009 eligible individuals). Response rates varied across age groups, ranging from 41.9% (20-29 years) to 76.1% (70-79 years). The majority of subscales were strongly associated with age and morbidity. Between genders only small, but clinically meaningful and statistically significant differences were found in five out of fifteen scales. When comparing Danish women 20 years ago and today, a tendency toward slightly improved function/reduced symptoms was observed, but the differences were small and statistically significant in only three subscales. CONCLUSION: This study is the first to present Danish general population reference values for the EORTC QLQ-C30 version 3.0. Age and morbidity are important potential confounders that must be taken into account in HRQoL studies.
Authors: Morten Aa Petersen; Mogens Groenvold; Neil K Aaronson; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Peter Fayers; Jorunn Helbostad; Bernhard Holzner; Stein Kaasa; Susanne Singer; Galina Velikova; Teresa Young Journal: Qual Life Res Date: 2010-10-23 Impact factor: 4.147
Authors: Young Ho Yun; Young Ae Kim; Young Hee Min; Yoon Jung Chang; Jongmog Lee; Moon Soo Kim; Hyun-Sung Lee; Jhingook Kim; Yong Soo Choi; Young Mog Shim; Jae Ill Zo Journal: Ann Surg Date: 2012-05 Impact factor: 12.969
Authors: Morten Aa Petersen; Mogens Groenvold; Neil K Aaronson; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Peter Fayers; Jorunn Helbostad; Bernhard Holzner; Stein Kaasa; Susanne Singer; Galina Velikova; Teresa Young Journal: Eur J Cancer Date: 2010-03-16 Impact factor: 9.162
Authors: Morten Aa Petersen; Johannes M Giesinger; Bernhard Holzner; Juan I Arraras; Thierry Conroy; Eva-Maria Gamper; Madeleine T King; Irma M Verdonck-de Leeuw; Teresa Young; Mogens Groenvold Journal: Qual Life Res Date: 2013-02-28 Impact factor: 4.147
Authors: Richard W Wilsnack; Sharon C Wilsnack; Arlinda F Kristjanson; Nancy D Vogeltanz-Holm; Gerhard Gmel Journal: Addiction Date: 2009-09 Impact factor: 6.526
Authors: Johannes Giesinger; Georg Kemmler; Verena Mueller; August Zabernigg; Beate Mayrbaeurl; Josef Thaler; Dietmar Ofner; Christian Pegger; Gerhard Rumpold; Barbara Weber; Barbara Sperner-Unterweger; Bernhard Holzner Journal: Qual Life Res Date: 2009-04-01 Impact factor: 4.147
Authors: Andreas Hinz; Joachim Weis; Hermann Faller; Elmar Brähler; Martin Härter; Monika Keller; Holger Schulz; Karl Wegscheider; Uwe Koch; Kristina Geue; Heide Götze; Anja Mehnert Journal: Support Care Cancer Date: 2018-04-26 Impact factor: 3.603
Authors: Claudia West; Steven M Paul; Laura Dunn; Anand Dhruva; John Merriman; Christine Miaskowski Journal: Oncol Nurs Forum Date: 2015-09 Impact factor: 2.172
Authors: Ellen Moseholm; Susan Rydahl-Hansen; Dorthe Overgaard; Hanne S Wengel; Rikke Frederiksen; Malene Brandt; Bjarne Ø Lindhardt Journal: Health Qual Life Outcomes Date: 2016-05-20 Impact factor: 3.186